ADMA Biologics

Yahoo Finance • yesterday

$ADMA Stock News: ADMA Biologics Investigated for Securities Fraud Following Channel Stuffing Claims – Investors Notified to Contact BFA Law

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story

Yahoo Finance • 3 days ago

ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating

SAN FRANCISCO, April 01, 2026 (GLOBE NEWSWIRE) -- Investors in ADMA Biologics, Inc. (NASDAQ: ADMA) saw the price of their shares slide over 16% on March 24, 2026 on short seller Culper Research’s report, “ADMA Biologics Inc. (ADMA): Chan... Full story

Yahoo Finance • 3 days ago

$ADMA Securities Alert: ADMA Biologics Investigated for Securities Fraud over Culper Research Report Revelation – Investors with Losses Urged to Contact BFA Law

NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story

Yahoo Finance • 8 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index down 0.8% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 8 days ago

Sector Update: Health Care Stocks Retreat Friday Afternoon

Health care stocks declined Friday afternoon, with the NYSE Health Care Index down 0.6% and the Stat PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 10 days ago

ADMA Biologics Addresses Misleading Short-Seller Report

RAMSEY, N.J. and BOCA RATON, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and... Full story

Yahoo Finance • 12 days ago

ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement

ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best NASDAQ stocks under $30 to buy. On March 2, ADMA Biologics announced a significant capital return initiative for 2026, targeting a total of ~$200 million in share repurchases. As a prima... Full story

Yahoo Finance • 13 days ago

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges

On February 17, 2026, B Group, Inc. disclosed a new position in Structure Therapeutics(NASDAQ:GPCR), acquiring 90,000 shares in the fourth quarter. What happened B Group disclosed in a Securities and Exchange Commission (SEC) filing date... Full story

Yahoo Finance • 20 days ago

A Look At ADMA Biologics (ADMA) Valuation After Recent Share Price Swings

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Recent performance snapshot and context ADMA Biologics (ADMA) has attracted fresh attention after... Full story

Yahoo Finance • 22 days ago

Why the Market Dipped But Adma Biologics (ADMA) Gained Today

In the latest trading session, Adma Biologics (ADMA) closed at $15.15, marking a +1.03% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.61%. Elsewhere, the Dow saw a downswing of 0.26%, wh... Full story

Yahoo Finance • 22 days ago

Asceniv (ADMA Biologics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Asceniv Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The Asceniv market is experiencing robust gr... Full story

Yahoo Finance • last month

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

ADMA Biologics, Inc. RAMSEY, N.J. and BOCA RATON, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufactu... Full story

Yahoo Finance • 2 months ago

Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out

On February 13, 2026, Ranger Investment Management disclosed a new position in Chime Financial(NASDAQ:CHYM), acquiring 591,255 shares in a trade estimated at $14.88 million. What happened According to the SEC filing dated February 13, 20... Full story

Yahoo Finance • 2 months ago

Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth

On February 13, 2026, Ranger Investment Management, L.P. disclosed a buy of 197,073 shares of Solaris Energy Infrastructure(NYSE:SEI), an estimated $9.53 million trade based on quarterly average pricing. What happened According to a fili... Full story

Yahoo Finance • 2 months ago

Stock Up 40% in a Year, $706 Million in Quarterly Sales: Why Boot Barn’s Trimmed Stake Deserves a Look

Ranger Investment Management disclosed on February 13, 2026, that it sold 99,800 shares of Boot Barn Holdings(NYSE:BOOT), an estimated $18.62 million transaction based on quarterly average pricing. What happened According to a recent SEC... Full story

Yahoo Finance • 4 months ago

These stocks are new additions to Mizuho’s ’Americas Top Picks’ list

Investing.com -- Mizuho has refreshed its monthly Americas Top Picks list, adding new high-conviction ideas selected by its U.S. equity analysts. The list highlights “our analysts’ highest conviction, catalyst-driven ideas,” Mizuho says,... Full story

Yahoo Finance • 4 months ago

High Growth Tech Stocks In The US Market To Watch

As the United States market enters December with a downturn in major indices like the Dow Jones, S&P 500, and Nasdaq due to risk-off sentiment impacting big tech and crypto-tied shares, investors are closely monitoring high growth opportun... Full story

Yahoo Finance • 4 months ago

ADMA Crosses Above Key Moving Average Level

In trading on Monday, shares of ADMA Biologics Inc (Symbol: ADMA) crossed above their 200 day moving average of $17.84, changing hands as high as $18.44 per share. ADMA Biologics Inc shares are currently trading up about 7.1% on the day.... Full story

Yahoo Finance • 4 months ago

Here’s Why Summers Value Partners Sold Inspire Medical Systems (INSP)

Summers Value Partners, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Summers Value Fund LP returned a net return of 20.4% net in Q3 2025, surpassing the... Full story

Yahoo Finance • 5 months ago

Exploring 3 High Growth Tech Stocks In The US Market

The United States market has recently experienced mixed performances, with the Dow Jones Industrial Average declining for two consecutive days while technology shares have shown signs of rebounding. Amidst these fluctuations, investors are... Full story